Healthcare technology company io Health announced it raised $2 million in seed funding for its AI platform, addressing clinician retention and documentation accuracy. The investment was led by Nina Capital amidst a staffing crisis in home health agencies. The platform has reduced clinician turnover by 36% and quality assurance rework by 25%.

The U.S. home health industry is valued at $162 billion, expected to reach $381 billion by 2033. Agencies face regulatory pressure, narrow margins, and a tight labor market. Documentation issues strain operations, increase administrative workload, and slow care coordination.

io Health’s platform streamlines documentation by integrating into current electronic medical records, reducing errors, shortening review cycles, and improving efficiency without major workflow changes. Performance data from customers like Elevate Home Health prompted the funding round.

The platform includes tools like ioAssist for real-time validation and compliance guidance, ioIQ for quality assurance automation, and ioDoc for generating digital patient handbooks. ioAssist serves as the flagship tool, delivering relevant data instantly within existing systems.

io Health plans to scale its Care Optimized platform for home health and hospice organizations with the seed funding. The platform’s tools address recurring documentation challenges, providing validation, compliance guidance, and automation to streamline processes.

Read more at Yahoo Finance: Home Health AI Startup io Health Secures $2M Seed Funding To Reduce Clinician Turnover By 36% With Smart Layer Technology